Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03259841
Other study ID # 2017-8-4
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 31, 2017
Est. completion date February 8, 2019

Study information

Verified date May 2019
Source SMG-SNU Boramae Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Investigators assess the gastric contents by ultrasonography in fasted patients undergoing cholecystectomy.


Description:

Investigators evaluate the gastric volume through cross sectional area and amount of clear fluid using Perlas grade by ultrasound in the supine and right lateral position of fasted patients undergoing cholecystectomy. Full stomach is regarded if solid gastric contents are detected or clear fluid is more than 1.5 ml/kg. The frequency of full stomach will be analyzed.


Recruitment information / eligibility

Status Completed
Enrollment 140
Est. completion date February 8, 2019
Est. primary completion date February 8, 2019
Accepts healthy volunteers No
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria:

- Patients scheduled for cholecystectomy

Exclusion Criteria:

- Presence of gastric anatomic abnormality or pathology

- A previous surgery of esophagus or stomach

- Current pregnancy

- Who could not lie in the right lateral decubitus (RLD) position

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Ultrasound assessment of gastric contet
Ultrasound assessment of gastric content is performed in fasted patient undergoing cholecystectomy.

Locations

Country Name City State
Korea, Republic of Seoul Metropolitan Government Seoul National University Boramae Medical Center Seoul

Sponsors (1)

Lead Sponsor Collaborator
SMG-SNU Boramae Medical Center

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Incidence of full stomach The incidence of full stomach is assessed by using ultrasonography. Before the induction of anesthesia
Secondary Cross sectional area of the stomach The cross sectional area of the stomach is assessed by using ultrasonography in the supine and right lateral positions. Before the induction of anesthesia
Secondary Volume of stomach The volume of stomach is assessed using the following formula; volume of stomach (mL) = 27.0 + 14.6 x cross-sectional area (right lateral position) - 1.28 x age. Before the induction of anesthesia
Secondary Type of gastric contents The type of gastric contents is assessed using ultrasonography. Before the induction of anesthesia
See also
  Status Clinical Trial Phase
Completed NCT03941288 - Efficacy and Safety of Cannabidiol for Gastroparesis and Functional Dyspepsia Phase 2
Terminated NCT03285308 - A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis 01 Phase 3
Completed NCT00733551 - Evaluation of the Safety, Tolerability and Pharmacokinetics of Repeat Oral Doses of GSK962040 Administered to Healthy Adult Subjects. Phase 1
Completed NCT01650714 - Endoscopic Full Thickness Biopsy, Gastric Wall. N/A
Completed NCT01452815 - Affects of Once-daily Oral Administration of TZP-102 on the Treatment of Symptoms Associated With Diabetic Gastroparesis Phase 2
Completed NCT01039974 - GSK962040 Drug-drug Interaction Study With Ketoconazole Phase 1
Terminated NCT04844190 - Use of EndoFLIP and Manometry Prior to G-POEM N/A
Enrolling by invitation NCT06215547 - Medtronic Enterra II Neurostimulator N/A
Completed NCT04026997 - A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis Phase 2
Completed NCT00562848 - A Study to Evaluate Safety, Side Effects, Muscle Activity and Speed of Gastric Emptying of GSK962040 Phase 1
Enrolling by invitation NCT04207996 - Vagus Nerve Response in Gastroparesis Patients
Completed NCT04607304 - ABCA2 GIRMS Analytical Validation Clinical Performance Study N/A
Recruiting NCT06068114 - Gastric Pathophysiology in Diabetes
Active, not recruiting NCT04300127 - Pioglitazone for Idiopathic Gastroparesis Early Phase 1
Recruiting NCT01696734 - Domperidone in Treating Patients With Gastrointestinal Disorders Phase 3
Terminated NCT04635306 - 13C-Spirulina Nitrogen Content GEBT Study N/A
Withdrawn NCT02420925 - Effect of Celiac Plexus Block on Gastric Emptying and Symptoms Caused by Gastroparesis N/A
Recruiting NCT00777439 - Domperidone for Refractory Gastrointestinal Disorders N/A
Terminated NCT00760461 - Domperidone in Refractory Gastroparesis Phase 2
Completed NCT00612014 - Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Severe Diabetic Gastroparesis Phase 2